Spinocerebellar Ataxia Sca clinical trials

Explore recruiting spinocerebellar ataxia sca clinical trials.

Recruiting spinocerebellar ataxia sca studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Spinocerebellar Ataxia Sca trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 1/2a, open-label trial to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of intrathecally administered VO659 in participants with spinocerebellar ataxia types 1, 3 and Huntington’s disease

Netherlands, Denmark, France, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Spinocerebellar Ataxia Sca trials by city

Spinocerebellar Ataxia Sca in Toronto Spinocerebellar Ataxia Sca in Vancouver Spinocerebellar Ataxia Sca in Montreal Spinocerebellar Ataxia Sca in Calgary Spinocerebellar Ataxia Sca in Edmonton Spinocerebellar Ataxia Sca in Ottawa Spinocerebellar Ataxia Sca in Winnipeg Spinocerebellar Ataxia Sca in Quebec City Spinocerebellar Ataxia Sca in Hamilton Spinocerebellar Ataxia Sca in Kitchener Spinocerebellar Ataxia Sca in London Spinocerebellar Ataxia Sca in Halifax Spinocerebellar Ataxia Sca in New York Spinocerebellar Ataxia Sca in Los Angeles Spinocerebellar Ataxia Sca in Chicago Spinocerebellar Ataxia Sca in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease